Cited by 984Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchPain Mechanisms and Treatments

The DOI matches its Crossref record; 349 of the 351 references it cites were found in a registry or an index.

Cannabinoids and the expanded endocannabinoid system in neurological disorders

Cristino, Luigia, Bisogno, Tiziana, Di Marzo, Vincenzo·2020·Nature Reviews Neurology

Open this paper in CoChat — free account

Abstract

Anecdotal evidence that cannabis preparations have medical benefits together with the discovery of the psychotropic plant cannabinoid Δ 9-tetrahydrocannabinol (THC) initiated efforts to develop cannabinoid-based therapeutics. These efforts have been marked by disappointment, especially in relation to the unwanted central effects that result from activation of cannabinoid receptor 1 (CB1), which have limited the therapeutic use of drugs that activate or inactivate this receptor. The discovery of CB2 and of endogenous cannabinoid receptor ligands (endocannabinoids) raised new possibilities for safe targeting of this endocannabinoid system. However, clinical success has been limited, complicated by the discovery of an expanded endocannabinoid system - known as the endocannabinoidome - that includes several mediators that are biochemically related to the endocannabinoids, and their receptors and metabolic enzymes. The approvals of nabiximols, a mixture of THC and the non-psychotropic cannabinoid cannabidiol, for the treatment of spasticity and neuropathic pain in multiple sclerosis, and of purified botanical cannabidiol for the treatment of otherwise untreatable forms of paediatric epilepsy, have brought the therapeutic use of cannabinoids and endocannabinoids in neurological diseases into the limelight. In this Review, we provide an overview of the endocannabinoid system and the endocannabinoidome before discussing their involvement in and clinical relevance to a variety of neurological disorders, including Parkinson disease, Alzheimer disease, Huntington disease, multiple sclerosis, amyotrophic lateral sclerosis, traumatic brain injury, stroke, epilepsy and glioblastoma.

Integrity signals

Registry

Crossref · 10.1038/s41582-019-0284-z

Cites

349 of 349 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Anti-carcinogenic activity of anandamide on human glioma in vitro and in vivo
Ma, C., Wu, T., Jiang, P., Li, Z., Chen, X., FU, K., WANG, W., & Gong, R. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4721 · Cited by 27
Retracted
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611618 · Cited by 1,711
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607

Show all 351 references

Sorted by citations

Items 501–600 of 984

An optimized spectrophotometric assay reveals increased activity of enzymes involved in 2‐arachidonoyl glycerol turnover in the cerebral cortex of a rat model of Alzheimer’s disease
Rodrigues, M. S., Ferreira, C., Dias, C., Pliássova, A., Souza, L. D. S., Ledo, A., Laranjinha, J. A. N., Cunha, R. A., & Köfalvi, A. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14944 · Cited by 7
Targeting Endocannabinoid Signaling in the Lateral Habenula as an Intervention to Prevent Mental Illnesses Following Early Life Stress: A Perspective
Shepard, R. D., & Nugent, F. S. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.689518 · Cited by 6
RETRACTED: Cannabidiol (CBD) From Non-Cannabis Plants: Myth or Reality?
Appendino, G., Taglialatela‐Scafati, O., & Muñóz, E. (2022) · Natural Product Communications · doi:10.1177/1934578x221098843 · Cited by 6
Retracted
Machine Learning and Computational Chemistry for the Endocannabinoid System
Atz, K., Guba, W., Grether, U., & Schneider, G. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2728-0_39 · Cited by 6
Maternal sevoflurane exposure induces neurotoxicity in offspring rats via the CB1R/CDK5/p-tau pathway
Wan, Y., Wu, Z., Li, X., & Zhao, P. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1066713 · Cited by 6
Neuronal Cannabinoid CB1 Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling
Costas‐Insua, C., Seijo-Vila, M., Blázquez, C., Blasco-Benito, S., Rodríguez‐Baena, F. J., Marsicano, G., Pérez-Gómez, E., Sánchez, C., Sánchez‐Laorden, B. L., & Guzmán, M. (2023) · Cancers · doi:10.3390/cancers15092439 · Cited by 6
Treadmill exercise modulates nigral and hippocampal cannabinoid receptor type 1 in the 6-OHDA model of Parkinson’s disease
Binda, K. H., Landau, A. M., Chacur, M., Brooks, D. J., & Real, C. C. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148436 · Cited by 6
A single-center real-life study on the use of medical cannabis in patients with dystonia
Anis, S., Faust‐Socher, A., Sverdlov, D., Lassman, S., Hezi, N., Anis, O., Leor, G., Korczyn, A. D., Giladi, N., & Gurevich, T. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1218300 · Cited by 6
Serum anandamide and lipids associated with linoleic acid can distinguish interstitial cystitis/bladder pain syndrome from overactive bladder: An exploratory study
Torimoto, K., Ueda, T., Gotoh, D., Kano, K., Miyake, M., Nakai, Y., Hori, S., Morizawa, Y., Onishi, K., Shimizu, T., et al. (2023) · LUTS Lower Urinary Tract Symptoms · doi:10.1111/luts.12501 · Cited by 6
Classification of Phytochemicals in Plants with Herbal Value
Abdelkhalek, S. T., Shi, J. H., Jin, M. X., Abdelgayed, S. S., & Wang, M. Q. (2024) · Reference series in phytochemistry · doi:10.1007/978-3-031-21973-3_12-2 · Cited by 8
Dual effect of anandamide on spinal nociceptive transmission in control and inflammatory conditions
Pontearso, M., Slepicka, J., Bhattacharya, A., Spicarova, D., & Paleček, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116369 · Cited by 6
Acupoints for Headache with Blood Stasis Syndrome: a Literature Study Based on Data Mining Technology
Shi, J.-Y., Li, T., Yang, H., Zhang, S., An, R., Mao, L., Li, Y., Li, Q., Luan, G.-Y., Shen, Y., et al. (2024) · Journal of Pain Research · doi:10.2147/jpr.s471441 · Cited by 6
FATTY ACIDS AS CELL SIGNALS IN INGESTIVE BEHAVIORS
Figlewicz, D. P., & Witkamp, R. F. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112985 · Cited by 6
Use of cannabis and its products among patients in a tertiary epilepsy center: A cross-sectional survey
Puteikis, K., & Mameniškienė, R. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.107214 · Cited by 6
PSNCBAM-1 analogs: Structural evolutions and allosteric properties at cannabinoid CB1 receptor
Meini, S., Gado, F., Stevenson, L., Digiacomo, M., Saba, A., Codini, S., Macchia, M., Pertwee, R. G., Bertini, S., & Manera, C. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112606 · Cited by 6
Recovery from Traumatic Brain Injury Following Treatment with Δ9-Tetrahydrocannabinol Is Associated with Increased Expression of Granulocyte-Colony Stimulating Factor and Other Neurotrophic Factors
Song, S., Kong, X., Wang, B., & Sanchez‐Ramos, J. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2020.0119 · Cited by 6
Administration of Δ 9 -Tetrahydrocannabinol Following Controlled Cortical Impact Restores Hippocampal-Dependent Working Memory and Locomotor Function
Song, S., Kong, X., Wang, B., & Sanchez‐Ramos, J. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0053 · Cited by 6
Slovenian Pet Owners' Experience, Attitudes, and Predictors Regarding Cannabinoid Use in Dogs and Cats
Tomsič, K., Rakinić, K., & Seliškar, A. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.796673 · Cited by 6
Cannabis, cannabinoids, and cannabis-based medicines: future research directions for analgesia
Badiola, I. J., Doshi, A., & Narouze, S. (2022) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2021-103109 · Cited by 6
Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury
Christie, B. R., Gross, A., Willoughby, A., Gräfe, E. L., Brand, J., Bosdachin, E., Reid, H. M. O., Acosta, C., & Eyolfson, E. (2023) · Journal of Visualized Experiments · doi:10.3791/64592 · Cited by 8
Role of integrating cannabinoids and the endocannabinoid system in neonatal hypoxic-ischaemic encephalopathy
Xiao, J., Zhou, Y., Sun, L., & Wang, H. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1152167 · Cited by 6
Electroacupuncture exerts antipruritic and anti-inflammatory effects on atopic dermatitis by activating CB2 receptor
Ge, W., Liu, X., Hu, X., Yang, Y., Chen, H., Zhanmu, O., Lin, S., Li, Y., Li, P., Tian, Q., et al. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01102-4 · Cited by 5
Cannabinoid Modulation of Excitability and Short-Term Neuronal Dynamics in the Dorsal and Ventral Hippocampus
Tsotsokou, G., Sotiropoulou, I.-M., Stampolitis, K., Oikonomou, G. D., Avdi, A.-P., & Papatheodoropoulos, C. (2025) · Biology · doi:10.3390/biology14060642 · Cited by 5
Ageing, Neurodegeneration and the Endocannabinoid System
Fernández‐Ruíz, J., Sagredo, O., Gómez‐Ruíz, M., & de Lago, E. (2025) · Current topics in behavioral neurosciences · doi:10.1007/7854_2025_597 · Cited by 5
The role of cannabinoid ligands in neurodegenerative diseases: Emerging anti-inflammatory, immunomodulation and disease-modifying perspectives
Baldasso, G. M., Paes, R. S., Moreira, A. F., Salvadori, S. G., Limberger, C., Roviezzo, F., Capasso, R., & Dutra, R. C. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108185 · Cited by 6
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus
Navarini, L., Vomero, M., Donato, S. D., Currado, D., Berardicurti, O., Marino, A., Bearzi, P., Biaggi, A., Ferrito, M., Ruscitti, P., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10071675 · Cited by 5
The effects of acute alcohol administration on circulating endocannabinoid levels in humans
Sloan, M. E., Grant, C. W., Stangl, B. L., Klepp, T., Brewton, H. W., Çınar, R., Kunos, G., & Ramchandani, V. A. (2022) · Addiction Biology · doi:10.1111/adb.13197 · Cited by 5
Deletion of Cryab increases the vulnerability of mice to the addiction-like effects of the cannabinoid JWH-018 via upregulation of striatal NF-κB expression
Sayson, L. V., Ortiz, D. M., Lee, H. J., Kim, M., Custodio, R. J. P., Yun, J., Lee, C. H., Lee, Y. S., Jin, H., Cheong, J. H., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1135929 · Cited by 6
Selected cannabis cultivars modulate glial activation: in vitro and in vivo studies
Fleisher‐Berkovich, S., Sharon, N., Ventura, Y., Feinshtein, V., Gorelick, J., Bernstein, N., & Ben‐Shabat, S. (2024) · Journal of Cannabis Research · doi:10.1186/s42238-024-00232-0 · Cited by 7
Formulation and Physicochemical Characterization of Terpenocannabinoid-Functionalized Hemp Oil Emulsifier: Assessment of Topical Anti-Inflammatory, Antinociceptive, Wound Healing Activity and Cutaneous Toxicity Effects
Metouekel, A., Zejli, H., Chebaibi, M., Lefrioui, Y., Bousta, D., Amri, H. E., Fahime, E. E., Kazzouli, S. E., & Brahmi, N. E. (2024) · Scientia Pharmaceutica · doi:10.3390/scipharm92030036 · Cited by 5
A journey through cannabidiol in Parkinson’s disease
Del-Bel, E., Barros, N., de Moraes, R. A. P. D. S., de Mattos, B. A., Alves-Fernandes, T. A., de Abreu, L. B., Nascimento, G. C., Escobar-Espinal, D. M., Pedrazzi, J. F. C., Jacob, G. A., et al. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.04.015 · Cited by 4
Comparison of Cannabis-Based Medicinal Product Formulations for Fibromyalgia: A Cohort Study
Sridharan, S., Erridge, S., Holvey, C., Coomber, R., Holden, W., Rucker, J., Platt, M. W., & Sodergren, M. H. (2024) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2024.2414073 · Cited by 5
Profiling Allosteric Modulators of CB 1 R with an Allosteric Fluoroprobe
Kosar, M., Perera, T., Ganzoni, R. L. Z., Sarott, R. C., Borrega‐Roman, L., Vitale, R. M., Ligresti, A., Rufer, A. C., Guba, W., Grether, U., et al. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202421885 · Cited by 6
Improvement in the Cognitive Function in Chronic Pain: Therapeutic Potential of the Endocannabinoid System
Karimi‐Haghighi, S., & Shaygan, M. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04814-8 · Cited by 5
An Amygdala‐hippocampus Circuit for Endocannabinoid Modulation of Anxiety Avoidance
Xue, B., Zhang, M., Bi, X., Lai, S., Bie, X., Dong, Y., Li, J., Gao, F., Zhang, X., & Wang, Y. (2025) · Advanced Science · doi:10.1002/advs.202505121 · Cited by 5
CB2R-cAMP-Epac1 pathway orchestrates epithelial–neural–immune interactions in atopic dermatitis
Hu, X., Luo, Y., Zhang, Y., Liu, K., Wu, L., Hou, J., Zhao, G., Wang, T., Liu, Y., Cheng, H., et al. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.08.021 · Cited by 5
N-Oleoyl Glycine and Its Derivatives Attenuate the Acquisition and Expression of Cocaine-Induced Behaviors
Shahen-Zoabi, S., Smoum, R., Beiser, T., Nemirovski, A., Mechoulam, R., & Yaka, R. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0005 · Cited by 5
Synthetic Cannabinoids and Cannabis: How the Patterns of Use Differ: Results from the European Web Survey on Drugs
López‐Pelayo, H., Madero, S., Gremeaux, L., Rönkä, S., & Matias, J. (2022) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-022-00919-6 · Cited by 5
Altered endocannabinoidome bioactive lipid levels accompany reduced DNBS-induced colonic inflammation in germ-free mice
Venneri, T., Giorgini, G., Leblanc, N., Flamand, N., Borrelli, F., Silvestri, C., & Marzo, V. D. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01823-1 · Cited by 5
Imaging and Genetic Tools for the Investigation of the Endocannabinoid System in the CNS
Kouchaeknejad, A., van der Walt, G., de Donato, M. H., & Puighermanal, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115829 · Cited by 6
Early endocannabinoid-mediated depolarization-induced suppression of excitation delays the appearance of the epileptic phenotype in synapsin II knockout mice
Forte, N. R., Nicois, A., Marfella, B., Mavaro, I., D’Angelo, L., Piscitelli, F., Scandurra, A., de Girolamo, P., Baldelli, P., Benfenati, F., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05029-7 · Cited by 5
Self-citation
Preclinical Evaluation of the Reversible Monoacylglycerol Lipase PET Tracer (R)‐[11C]YH132: Application in Drug Development and Neurodegenerative Diseases
He, Y., Delparente, A., Jie, C. V. M. L., Keller, C., Humm, R., Heer, D., Collin, L., Schibli, R., Gobbi, L. B., Grether, U., et al. (2024) · ChemBioChem · doi:10.1002/cbic.202300819 · Cited by 5
Canonical DDR activation by EMT inducing agent 5-Fluorouracil is modulated by a cannabinoid based combinatorial approach via inducing autophagy and suppression of vimentin expression
Mir, K. B., Chakraborty, S., Amin, T., Kumar, A., War, A. R., Nalli, Y., Kumar, R., Kumar, L. D., Ali, A., & Goswami, A. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116126 · Cited by 5
Alterations in plasma endocannabinoid concentrations among individuals with major depression treated with electroconvulsive therapy
Bloemhof‐Bris, E., Meiri, D., Sulimani, L., Genesh, S. N., Wexler, G., Cohen, I., Salama, A., Burshtein, I., Hirschmann, S., Feffer, K., et al. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115967 · Cited by 7
Tetrahydrocannabinol (THC)-modified screen-printed carbon electrodes (SPCEs): insights into stability
Grewal, R., Ortega, G. A., Viltres, H., Srinivasan, S., & Rajabzadeh, A. R. (2024) · RSC Applied Interfaces · doi:10.1039/d4lf00110a · Cited by 5
Grain actives modulate gut microbiota to improve obesity-related metabolic diseases: A review
Zhao, Y., Liu, J., Sun, S., Zheng, M., Liu, M., Liu, J., & Liu, H. (2024) · Food Research International · doi:10.1016/j.foodres.2024.115367 · Cited by 7
Development and Characterization of New Cannabidiol‐Loaded Polycaprolactone Nanoparticles for Increased Bioavailability
Ediz, E. F., Kars, M. D., & Çetin, K. (2024) · ChemistrySelect · doi:10.1002/slct.202403609 · Cited by 5
Plant-derived cannabinoids for treatment of spasticity in children and adolescents with severe cerebral palsy: Double-blind, placebo-controlled trial
Stefanović, M., Osredkar, D., Rener‐Primec, Z., Peterlin, J., Laptoš, T., & Neubauer, D. (2024) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2024.11.007 · Cited by 5
A novel injectable nanotherapeutic platform increasing the bioavailability and anti-tumor efficacy of Arachidonylcyclopropylamide on an ectopic non-small cell lung cancer xenograft model: A randomized controlled trial
Boyacıoğlu, Ö., Varan, C., Bilensoy, E., Aykut, G., Reçber, T., Nemutlu, E., Kılıç, N., & Korkusuz, P. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.125153 · Cited by 5
Cannabidiol abrogates cue-induced anxiety associated with normalization of mitochondria-specific transcripts and linoleic acid in the nucleus accumbens shell
Ferland, J. N., Chisholm, A., Abdalla, J., Çınar, R., Johnson, C. T., Bradshaw, H. B., & Hurd, Y. L. (2025) · Molecular Psychiatry · doi:10.1038/s41380-024-02881-2 · Cited by 5
Cerebrovascular Complications Associated with Marijuana Use
Moustafa, B., & Testai, F. D. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01113-2 · Cited by 5
The Endocannabinoid System in the Central Nervous System: Emphasis on the Role of the Mitochondrial Cannabinoid Receptor 1 (mtCB1R)
Maya-López, M., Zazueta, C., Retana‐Márquez, S., Ali, S. F., Karasu, Ç., Onaivi, E. S., Aschner, M., & Santamarı́a, A. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_461-1 · Cited by 6
Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) Study
Kim, H. K., Zai, G. C., Müller, D. J., Husain, M. I., Lam, R. W. M., Frey, B. N., Soares, C. N., Parikh, S. V., Milev, R. V., Foster, J. A., et al. (2022) · Pharmacopsychiatry · doi:10.1055/a-1872-0844 · Cited by 5
Combinatorial approaches for treating neuropsychiatric social impairment
Don, W., Tsheringla, S., McPartland, J. C., & Allsop, S. A. (2022) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2021.0051 · Cited by 6
LC–MS/MS Analysis of AEA and 2-AG
Battista, N., Fanti, F., & Sergi, M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2728-0_4 · Cited by 5
Cannabinoids activate the insulin pathway to modulate mobilization of cholesterol in C. elegans
Cravero, B. H., Gallino, S., Florman, J., Vranych, C. V., Diaz, P., Elgoyhen, A. B., Alkema, M. J., & de Mendoza, D. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010346 · Cited by 5
Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells
Boyacıoğlu, Ö., & Korkusuz, P. (2022) · Advances in experimental medicine and biology · doi:10.1007/5584_2022_748 · Cited by 5
A Cross Talk between the Endocannabinoid System and Different Systems Involved in the Pathogenesis of Hypertensive Retinopathy
Alswailmi, F. K. (2023) · Pharmaceuticals · doi:10.3390/ph16030345 · Cited by 5
Cannabis: Drug of Abuse and Therapeutic Agent, Two Sides of the Same Coin
Canseco-Alba, A., & Rodrı́guez–Manzo, G. (2023) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.23000112 · Cited by 6
Quercetin-loaded nanophytosome ameliorates early life stress-induced hippocampal oxido-inflammatory damages
Eslami, A., Moghaddam, A. H., Jelodar, S. K., & Ranjbar, M. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.03.004 · Cited by 4
Recent Preclinical Evidence on Phytocannabinoids in Neurodegenerative Disorders: A Focus on Parkinson’s and Alzheimer’s Disease
Blebea, N. M., Pușcașu, C., Hancu, G., Stăniguț, A. M., & Chiriță, C. (2025) · Pharmaceuticals · doi:10.3390/ph18060890 · Cited by 5
Uncovering the molecular targets of phytocannabinoids: mechanistic insights from inverse molecular docking fingerprint approaches
Ravnik, V., Jukič, M., Furlan, V., Maver, U., Rožanc, J., & Bren, U. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1611461 · Cited by 4
Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?
Botticelli, L., Bonaventura, E. M. D., Einaudi, G., Provensi, G., Costa, A., D’Addario, C., Cifani, C., & Bonaventura, M. V. M. D. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70196 · Cited by 5
Lifespan changes in cannabinoid 1 receptor mRNA expression in the female C57BL/6J mouse brain
Li, X., Zhao, G., Huang, H., Ye, J., Xu, J., Zhou, Y., Zhu, X., Wang, L., & Wang, F. (2022) · The Journal of Comparative Neurology · doi:10.1002/cne.25427 · Cited by 4
The therapeutic use of cannabis and cannabinoids
Silva, J. P., & Carvalho, F. D. (2022) · Revista Española de Drogodependencias · doi:10.54108/10032 · Cited by 4
Bioelectronic sensing platform emulating the human endocannabinoid system for assessing and modulating of cannabinoid activity
Cho, H.-J., Oh, D. E., Nam, Y., Lee, S. H., & Kim, T. H. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116686 · Cited by 4
Study protocol for the iMarkHD study in individuals with Huntington's disease
van Wamelen, D. J., Martin, N. H., Mákos, O., Badenoch, J., Valera‐Bermejo, J. M., Hartmann, M., Cristales, A. R., Wood, T., Veronese, M., Moretto, M., et al. (2024) · Journal of Huntington s Disease · doi:10.1177/18796397241288165 · Cited by 4
Δ9-tetrahydrocannabinol induces blood-brain barrier disruption: Involving the activation of CB1R and oxidative stress
Zhang, Q., Huang, W., Li, T., Wang, X., Lai, X., Hu, W., Li, Z., Zeng, X., Huang, J. A., & Zhang, R. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110366 · Cited by 4
Endocannabinoid signaling in epilepsy
Zeng, C., & Chen, C. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107074 · Cited by 4
Tetrahydrocannabivarin (THCV) Dose Dependently Blocks or Substitutes for Tetrahydrocannabinol (THC) in a Drug Discrimination Task in Rats
Kayır, H., Kouroukis, L., Aziz, I., & Khokhar, J. Y. (2025) · Biomolecules · doi:10.3390/biom15091329 · Cited by 4
Combination of CBD with minor cannabinoid CBDV suppresses CXCR4 via CB2 receptor and alleviates colitis in mice
Gelfand, A., Besser, E., Procaccia, S., Cohen, J., Steinberg, M., Kleifeld, O., & Meiri, D. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118768 · Cited by 4
Astrocyte CB1 receptors drive blood-brain barrier disruption in central nervous system inflammatory disease
Colomer, T., Bernal‐Chico, A., Sánchez-Martín, E., Moreno‐García, A., Baraibar, A. M., Uribe-Irusta, A., Iriarte-Sarria, A., Beriain, S., Skupio, U., Gatuingt-Chasseriaud, C., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03708-3 · Cited by 4
Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and Behavior
Ganesh, S., Cortes-Briones, J., Martin, A. M. S., Skosnik, P. D., D’Souza, D. C., & Ranganathan, M. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0166 · Cited by 4
Endocannabinoids, anandamide and 2-AG, regulate mechanosensitivity of mucosal afferents in the Guinea pig bladder
Ramsay, S. D., Spencer, N. J., & Zagorodnyuk, V. P. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175624 · Cited by 4
The peripheral endocannabinoid system and its association with biomarkers of inflammation in untreated patients with multiple sclerosis
Gustavsen, S., Olsson, A., Oturai, A. B., Línnet, K., Thomsen, R., Rasmussen, B. S., Jørgensen, C. F., Langkilde, A. R., Sørensen, P. S., Sellebjerg, F. T., et al. (2023) · European Journal of Neurology · doi:10.1111/ene.15930 · Cited by 4
Monoacylglycerol Lipase and Cyclooxygenase-2 Expression in Osteoarthritic Human Knees
Yu, M., Gordon, C., Studholme, K. M., Hassan, M., Sadar, F., Khan, A., Nicholson, J., Komatsu, D. E., & Kaczocha, M. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0042 · Cited by 4
Sculptor and Destroyer
Mattson, M. P. (2023) · The MIT Press eBooks · doi:10.7551/mitpress/14422.001.0001 · Cited by 4
Enhancing Drug Discovery and Development through the Integration of Medicinal Chemistry, Chemical Biology, and Academia-Industry Partnerships: Insights from Roche’s Endocannabinoid System Projects
Aebi, J. D., Atz, K., Ametamey, S. M., Benz, J., Blaising, J., Butini, S., Campiani, G., Carreira, E. M., Collin, L., de Lago, E., et al. (2024) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2024.499 · Cited by 5
Myogenic Classical Endocannabinoids, Their Targets and Activity
Balezina, O. P., Tarasova, E. O., & Bogacheva, P. O. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924100080 · Cited by 4
Accidental Synthetic Cannabinoid Poisoning in a Pediatric Patient: A Case Report
Gonedes, A. J., & Boccio, E. (2024) · Cureus · doi:10.7759/cureus.74936 · Cited by 4
The Administration of Cannabinoid Receptor 2 Agonist Decreases Binge-like Intake of Palatable Food in Mice
Rodríguez–Serrano, L. M., & Chávez–Hernández, M. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051981 · Cited by 4
Prenatal alcohol exposure dysregulates the expression of clock genes and alters rhythmic behaviour in mice
Reina-Campos, M., Gallego‐Landin, I., Medrano, M., García-Baos, A., & Valverde, O. (2025) · Open Biology · doi:10.1098/rsob.250141 · Cited by 4
Lipid Signalling in Human Immune Response and Bone Remodelling under Microgravity
Fava, M., Leuti, A., & Maccarrone, M. (2020) · Applied Sciences · doi:10.3390/app10124309 · Cited by 4
Bench to bedside: Multiple facets of cannabinoid control in epilepsy
Xue, B., Zhang, X., & Wang, Y. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104898 · Cited by 4
Cannabinoid Receptor-2 Activation in Keratinocytes Contributes to Elevated Peripheral β-Endorphin Levels in Patients With Obstructive Jaundice
Tao, K., Zhu, J., Wei, K., Meng, X., Zhu, M., Tao, Y. K., Lu, Z., & Yu, W. (2021) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005405 · Cited by 4
Cannabinoids, the Endocannabinoid System, and Cognitive Functions: Enemies or Friends?
Kitchigina, V. F. (2021) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-021-01148-5 · Cited by 7
Molecular Findings Guiding the Modulation of the Endocannabinoid System as a Potential Target to Treat Schizophrenia
Zuccoli, G. S., Brandão‐Teles, C., Vieira, G. M., Gomes, F. V., & Crunfli, F. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-97182-3_7 · Cited by 4
The impact of biotechnology and genomics on an ancient crop: Cannabis sativa
Gilchrist, E. J., Wang, S., & Quilichini, T. D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91601-1.00009-2 · Cited by 4
Need for Methods to Investigate Endocannabinoid Signaling
Maccarrone, M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2728-0_1 · Cited by 4
Electrophysiology of Endocannabinoid Signaling
Musella, A., & Centonze, D. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2728-0_38 · Cited by 4
Short and efficient synthesis of alkylresorcinols: a route for the preparation of cannabinoids
Villano, R., Straker, H. E., & Marzo, V. D. (2022) · New Journal of Chemistry · doi:10.1039/d2nj03547b · Cited by 4
Cocaine-induced loss of LTD and social impairments are restored by fatty acid amide hydrolase inhibition
Alegre-Zurano, L., Cáceres-Rodríguez, A., Berbegal-Sáez, P., Lassalle, O., Manzoni, O. J., & Valverde, O. (2023) · Scientific Reports · doi:10.1038/s41598-023-45476-7 · Cited by 4
Canabidiol para o controle da dor em pequenos animais: Revisão
Sousa, L. T. N., Daibert, A. P. F., & Dias, A. M. N. (2023) · PubVet · doi:10.31533/pubvet.v17n11e1477 · Cited by 4
How depression and antidepressant drugs affect endocannabinoid system?—review of clinical and preclinical studies
Dragon, J., & Obuchowicz, E. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02938-z · Cited by 4
Roadmap for the expression of canonical and extended endocannabinoid system receptors and metabolic enzymes in peripheral organs of preclinical animal models
Rosado‐Franco, J. J., Ellison, A. L., White, C. J., Price, A., Moore, C., Williams, R. E., Fridman, L., Weerts, E. M., & Williams, D. W. (2024) · Physiological Reports · doi:10.14814/phy2.15947 · Cited by 7
Neurological Complications of Cannabinoids
Humayun, M., Suárez, J. I., & Shah, V. A. (2024) · Seminars in Neurology · doi:10.1055/s-0044-1787570 · Cited by 3
Inhibition of diacylglycerol lipase α induced blood–brain barrier breach in female Sprague–Dawley rats
Liktor‐Busa, E., Levine, A. A., Young, S. J., Bader, C., Palomino, S. M., Polk, F. D., Couture, S. A., Pires, P. W., Anderson, T. R., & Largent‐Milnes, T. M. (2025) · The Journal of Physiology · doi:10.1113/jp287680 · Cited by 3
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Epilepsy
Cowley, I., Erridge, S., Aggarwal, A., Evans, L., Varadpande, M., Clarke, E., McLachlan, K., Coomber, R., Iqbal, A., Rucker, J., et al. (2025) · Brain and Behavior · doi:10.1002/brb3.70490 · Cited by 3
Cannabidiolic Acid Rescues Deficits in Hippocampal Long-Term Potentiation in Models of Alzheimer’s Disease: An Electrophysiological and Proteomic Analysis
Gil, B., Sullivan, M., Scaife, C., Glennon, J. C., & Herron, C. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104944 · Cited by 3
Methods for Assessing MAGL Enzymatic Activity: An Extensive Review of Past and Emerging Approaches
Bononi, G., Landucci, E., Stefano, M. D., Piazza, L., Bertini, S., Macchia, M., & Granchi, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199829 · Cited by 5

Authors: Cristino, L., Bisogno, T., & Di Marzo, V.
Affiliations: Istituto di Chimica Biomolecolare (IT)
Istituto di Farmacologia Traslazionale (IT)
ORCID: Cristino, Luigia
Bisogno, Tiziana
Di Marzo, Vincenzo
Venue: Nature Reviews Neurology
Publisher: Springer Science and Business Media LLC
Published: 2019-12-12
Volume: 16
Issue: 1
Pages: 9-29
ISSN: 1759-4758 (ISSN-L)
1759-4766
DOI: 10.1038/s41582-019-0284-z
OpenAlex: W2996080671
Cited by: 970
References: 351
Citations by year: 2026: 79 · 2025: 126 · 2024: 173 · 2023: 185 · 2022: 183 · 2021: 142 · 2020: 82
FWCI: 13.33
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Reviews Neurology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
Keywords: cannabinoids, endocannabinoid system, endocannabinoidome, neurological disorders, CB1 receptor, CB2 receptor, nabiximols, cannabidiol, THC, multiple sclerosis, spasticity, neuropathic pain, pediatric epilepsy, Parkinson's disease, Alzheimer's disease, Huntington's disease, amyotrophic lateral sclerosis, traumatic brain injury, stroke, glioblastoma
MeSH terms: Analgesics, Animals, Cannabidiol, Cannabinoids, Drug Combinations, Humans, Nervous System Diseases, Dronabinol, Receptor, Cannabinoid, CB1, Receptor, Cannabinoid, CB2, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cannabinoids and the expanded endocannabinoid system in neurological disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks